CYRX Stock Summary and Trading Ideas (Cryoport | NASDAQ:CYRX)

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Cryoport trades on the NASDAQ stock market under the symbol CYRX.

As of April 19, 2024, CYRX stock price declined to $16.13 with 453,118 million shares trading.

CYRX has a beta of 2.45, meaning it tends to be more sensitive to market movements. CYRX has a correlation of 0.22 to the broad based SPY ETF.

CYRX has a market cap of $789.78 million. This is considered a Small Cap stock.

Last quarter Cryoport reported $57 million in Revenue and -$.30 earnings per share. This fell short of revenue expectation by $-1 million and missed earnings estimates by -$.01.

In the last 3 years, CYRX stock traded as high as $86.30 and as low as $9.00.

The top ETF exchange traded funds that CYRX belongs to (by Net Assets): VTI, IWM, VXF, VB, VBK.

CYRX has underperformed the market in the last year with a price return of -20.9% while the SPY ETF gained +21.2%. However, in the short term, CYRX had mixed performance relative to the market. It has outperformed in the last 3 months, returning +13.0% vs +4.3% return in SPY. But in the last 2 weeks, CYRX shares have been beat by the market, returning -13.1% compared to an SPY return of -3.5%.

CYRX support price is $15.88 and resistance is $17.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CYRX stock will trade within this expected range on the day.